--- title: "Shougang Lanza rushes to the Hong Kong stock market: annual revenue of 520 million, net loss of 330 million" type: "News" locale: "en" url: "https://longbridge.com/en/news/280730311.md" description: "Shougang Lanza Technology Co., Ltd. updated its prospectus and plans to list on the Hong Kong Stock Exchange. The company reported revenue of 593 million yuan in 2023, with a net loss of 110 million yuan. It is expected that revenue will continue to decline in 2024 and 2025, reaching 564 million yuan and 522 million yuan, respectively, with losses expanding to 246 million yuan and 325 million yuan. Shougang Lanza mainly engages in the sales and solutions of low-carbon products, with cash and cash equivalents continuously decreasing. Shougang Group is the major shareholder, and the executive director is Dong Yan" datetime: "2026-03-27T05:00:54.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280730311.md) - [en](https://longbridge.com/en/news/280730311.md) - [zh-HK](https://longbridge.com/zh-HK/news/280730311.md) --- # Shougang Lanza rushes to the Hong Kong stock market: annual revenue of 520 million, net loss of 330 million Leidi Network, Lei Jianping, March 27 Shougang Lanza Technology Co., Ltd. (referred to as "Shougang Lanza") recently updated its prospectus and is preparing to list on the Hong Kong Stock Exchange. Shougang Lanza's revenue is expected to decline in 2024 and 2025, and losses are continuing to expand. Annual revenue of 520 million, net loss of 330 million Shougang Lanza was established in 2011 and has been deeply engaged in the global CCUS industry. Shougang Lanza's business model mainly includes the sale of low-carbon products (mainly ethanol and microbial protein) and providing comprehensive low-carbon solutions for industrial customers. Shougang Lanza's revenue mainly comes from the sale of ethanol and microbial protein, as well as by-products such as biogas and crude alcohol. The prospectus shows that Shougang Lanza's revenue for 2023, 2024, and 2025 is expected to be 593 million, 564 million, and 522 million respectively; gross profit is expected to be 17.71 million, -93.35 million, and -128 million respectively; Shougang Lanza's losses for 2023, 2024, and 2025 are expected to be 110 million, 246 million, and 325 million respectively. As of December 31, 2024, Shougang Lanza holds cash and cash equivalents of 68.74 million. Overall, Shougang Lanza's cash and cash equivalents have been in a continuous decline over the past two years Shougang Group is the major shareholder. The executive director of Shougang Lanza is Ms. Dong Yan, and the non-executive directors are Dr. Ma Lishen, Dr. Jennifer Holmgren, Lin Siyu, Dr. Wu Bin, Zhang Dan, and Ms. Wang Yan; the independent non-executive directors are Dr. Hu Shanying, Dr. Feng Yinggang, Dr. Chen Xin, and Kong Xiangda. In 2016, Shougang Lanza received an investment of 115 million yuan from the Caofeidian Fund, with a valuation of 565 million yuan, and a price per share of 2.69 yuan; in February 2018, it received 150 million yuan in financing from Shanghai Dehui, with a post-investment valuation of 850 million yuan and a price per share of 3.33 yuan; In July 2020, Shougang Lanza secured 300 million yuan in financing, of which Shanghai Dehui invested 120 million yuan, and Mitsui & Co., Ltd. invested 60 million yuan, with a post-investment valuation of 1.99 billion yuan and a cost per share of 6.61 yuan; in 2021, it received 260 million yuan in financing, with a post-investment valuation of 2.56 billion yuan; in April 2022, it secured 300 million yuan in financing, with a post-investment valuation of 4.3 billion yuan and a cost per share of 11.94 yuan. Before the IPO, Shougang Group directly held approximately 26.54% of the total issued share capital of the company; NZ Tang Ming directly held approximately 9.48% of the total issued share capital of the company; and the Caofeidian Fund directly held approximately 3.54% of the total issued share capital of the company. NZ Tang Ming is a limited company registered under New Zealand law, primarily engaged in equity investment. NZ Tang Ming is owned by executive director Dong Yan, Beijing Shouye Xinyuan Technology Development Co., Ltd. ("Shouye Xinyuan"), and an independent third party, holding 65.57%, 30.89%, and 3.54% of the equity, respectively. Shouye Xinyuan is ultimately controlled by the Changping State-owned Assets Supervision and Administration Commission. Shanghai Mingda Industrial holds 15.34%, Lanza Technology Hong Kong holds 9.31%, Ruihong Investment holds 7.27%, Mitsui & Co., Ltd. holds 4.61%, Shanghai Dehui holds 4.56%, Caofeidian Fund holds 3.54%, Guofu Yonglang holds 3.34%, and Pingyang Puyi holds 2.92% Guangzhou Panmei holds 2.18%, Tang Ming Hong Kong and Zhuhai Jinsheng hold 1.26% each, Beijing Jiaye Yuan holds 0.99%, Qingdao Baiwei Zhihhe holds 0.42%, Shanghai Guochen holds 2.07%, Jiaxing Guohui holds 1.42%, and Binhai Silicon Carbide Products, Jiaxing Tianchen, and Jinxin Kaiying hold 1.16% each. ——————————————— ### Related Stocks - [02553.HK](https://longbridge.com/en/quote/02553.HK.md) - [159639.CN](https://longbridge.com/en/quote/159639.CN.md) ## Related News & Research - [Tencent, CATL Join 10 Million-Ton Carbon Credit Push](https://longbridge.com/en/news/286929608.md) - [Quantinuum Shares Indicated To Open At $61 In Nasdaq Debut Versus $60 IPO Price](https://longbridge.com/en/news/288744016.md) - [Quantinuum Announces Pricing of Upsized Initial Public Offering | QNT Stock News](https://longbridge.com/en/news/288641436.md) - [ZAWYA: RAKEZ intensifies industry engagement to support business resilience and continuity](https://longbridge.com/en/news/288690999.md) - [TIMELINE-How the Mandelson affair caused a crisis for UK PM Starmer](https://longbridge.com/en/news/288303152.md)